id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id FDA-2017-V-7023-0003,FDA,FDA-2017-V-7023,Variance Approval from FDA CDRH to PLATINUM AVL,Other,Approval for Variance (VRA),2018-01-16T05:00:00Z,2018,1,2018-01-16T05:00:00Z,,2018-01-16T19:48:52Z,,0,0,0900006482e119c0 FDA-2017-V-7023-0001,FDA,FDA-2017-V-7023,Variance Application from Platinum AVL,Other,Application for Variance (VAR),2017-12-29T05:00:00Z,2017,12,2017-12-29T05:00:00Z,,2017-12-29T16:37:20Z,,0,0,0900006482d83c59 FDA-2017-V-7023-0002,FDA,FDA-2017-V-7023,Acknowledgement Letter from FDA DDM to Platinum AVL,Other,Acknowledgement Letter/Receipt,2017-12-29T05:00:00Z,2017,12,2017-12-29T05:00:00Z,,2017-12-29T16:37:25Z,,0,0,0900006482d83c5c